Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Israel, D. I.
Right arrow Articles by Kaufman, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Israel, D. I.
Right arrow Articles by Kaufman, R. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Retroviral-mediated transfer and amplification of a functional human factor VIII gene

DI Israel and RJ Kaufman

Genetics Institute, Cambridge, MA 02140.

Hemophilia A results from a deficiency in factor VII (FVIII), a cofactor in the intrinsic pathway of blood coagulation. As an approach toward genetic therapy of this disease, we constructed a retroviral vector encoding human FVIII and a selectable and amplifiable genetic marker, human adenosine deaminase (Ada). A retrovirus packaging line was transfected with this vector and stable transformants were selected for Ada expression. Isolated transformants produced both FVIII activity in the conditioned medium and retrovirus capable of transferring the Ada selectable marker and FVIII expression to the mouse 3T3 fibroblasts. Selection of virus-producer cell lines for increasing levels of Ada expression yielded a 20-fold increase in both FVIII expression and viral titer. Similarly, selection of infected 3T3 fibroblasts for Ada gene amplification yielded a 20-fold increase in FVIII expression. The results demonstrate the feasibility of retrovirus- mediated transfer of human FVIII, and also the utility of selection for gene amplification to increase retrovirus titers in producer cell lines as well as expression levels in infected cells.

Volume 75, Issue 5, pp. 1074-1080, 03/01/1990
Copyright © 1990 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
T. VandenDriessche, V. Vanslembrouck, I. Goovaerts, H. Zwinnen, M.-L. Vanderhaeghen, D. Collen, and M. K. L. Chuah
Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice
PNAS, August 31, 1999; 96(18): 10379 - 10384.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Connelly, J. L. Andrews, A. M. Gallo, D. B. Kayda, J. Qian, L. Hoyer, M. J. Kadan, M. I. Gorziglia, B. C. Trapnell, A. McClelland, et al.
Sustained Phenotypic Correction of Murine Hemophilia A by In Vivo Gene Therapy
Blood, May 1, 1998; 91(9): 3273 - 3281.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
L. W. Hoyer
Hemophilia A
N. Engl. J. Med., January 6, 1994; 330(1): 38 - 47.
[Full Text]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1990 by American Society of Hematology         Online ISSN: 1528-0020